GlassScriptPhysician profile
Walter S James
NPI 1972552008
$335.41
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
See the full distribution for Sleep Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $146 · 2021: $75.31.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Octapharma USA, INC. | $79.90 | 2020 | |
| Jazz Pharmaceuticals INC. | $75.64 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $54.75 | 2020-2021 | |
| Harmony Biosciences LLC | $44.65 | 2020 | |
| Mallinckrodt Enterprises LLC | $19.30 | 2019 | |
| Mylan Specialty L.P. | $16.64 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $16.39 | 2021 | |
| Glaxosmithkline, LLC. | $14.42 | 2021 | |
| Grifols USA, LLC | $13.72 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.